A phase 2 study of sitravatinib in metastatic, pre-treated, triple negative breast cancer, NCT # 04123704

被引：0
|
作者：
Shafaee, Maryam Nemati
Otte, Kristen
Neill, Nicholas J.
Osborne, Kent C.
Westbrook, Thomas F.
Hilseneck, Susan
Ellis, Matthew J.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-OT2-28-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-28-01
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Duda, Dan G.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Significant Efficacy in a Phase 2 Study of NKTR-102, a Novel Polymer Conjugate of Irinotecan, in Patients with Pre-Treated Metastatic Breast Cancer (MBC)
    Awada, A.
    Chan, S.
    Jerusalem, G.
    Huizing, M.
    Coleman, R. E.
    Mehdi, A.
    O'Reilly, S. M.
    Hamm, J. T.
    Patel, T.
    Hannah, A. L.
    Masuoka, L. K.
    Garcia, A. A.
    Perez, E. A.
    CANCER RESEARCH, 2010, 70
  • [33] Dose finding study of Taxotere in pre-treated patients with metastatic breast cancer: A phase II study of the GON ("Grupo Oncologico del Norte")
    Palacio, I
    Fra, J
    Lacave, AJ
    Esteban, E
    Vieitez, JM
    Sande, LMG
    Muniz, I
    Estrada, E
    Puertas, J
    Sala, M
    ANNALS OF ONCOLOGY, 1998, 9 : 23 - 23
  • [34] Prognostic and predictive factors of eribulin in patients with heavily pre-treated metastatic breast cancer
    Chen, Pei-Hsin
    Yeh, Dah-Cherng
    Tung, Heng-Hsin
    Lin, Chin-Yao
    MEDICINE, 2021, 100 (47)
  • [35] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Bartsch, Rupert
    Wenzel, Catharina
    Gampenrieder, Simon P.
    Pluschnig, Ursula
    Altorjai, Gabriela
    Rudas, Margaretha
    Mader, Robert M.
    Dubsky, Peter
    Rottenfusser, Andrea
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 903 - 910
  • [36] Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
    Rupert Bartsch
    Catharina Wenzel
    Simon P. Gampenrieder
    Ursula Pluschnig
    Gabriela Altorjai
    Margaretha Rudas
    Robert M. Mader
    Peter Dubsky
    Andrea Rottenfusser
    Michael Gnant
    Christoph C. Zielinski
    Guenther G. Steger
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 903 - 910
  • [37] Vinorelbine; An active and well tolerated treatment for anthracycline pre-treated metastatic breast cancer
    Mustafa, M
    Walsh, G
    Smith, IE
    Johnston, SRD
    BRITISH JOURNAL OF CANCER, 1999, 80 : 103 - 103
  • [38] Phase II trial of selinexor for metastatic triple negative breast cancer
    Han, H. S.
    Ismail-Khan, R.
    Carney, D.
    Extermann, M.
    Hogue, D.
    Soliman, H.
    Loftus, L.
    Lee, J. K.
    Sullivan, D.
    CANCER RESEARCH, 2017, 77
  • [39] The inflammatory pre-metastatic niche in reliably metastatic models of triple negative breast cancer
    Balestrieri, Kassondra
    Pittman, H. Keith
    Britt, Matthew
    Ramez, Mohamed
    Vohra, Nasreen
    Verbanac, Kathryn
    CANCER RESEARCH, 2016, 76
  • [40] Apoptotic and Metastatic Effect of Taurine in Triple Negative Breast Cancer Treated with Doxorubicin
    Gedikli, Esra
    Dincsoy, Adnan Berk
    Erdem, Aysen
    ACTA PHYSIOLOGICA, 2023, 237 : 23 - 23
12345